A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)

PHASE2CompletedINTERVENTIONAL
Enrollment

455

Participants

Timeline

Start Date

April 8, 2004

Primary Completion Date

August 6, 2004

Study Completion Date

August 6, 2004

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Placebo

One, two, or four sprays of placebo are administered to the left and right nostrils twice a day (in the morning and at night) for 2 weeks.

DRUG

Mometasone furoate

One spray of mometasone furoate 50 mcg is administered to the left and right nostrils in the morning, and one spray of placebo to the left and right nostrils at night for 2 weeks. The daily dose of mometasone furoate is 100 mcg.

DRUG

Mometasone furoate

Two sprays of mometasone furoate 50 mcg are administered to the left and right nostrils in the morning, and two sprays of placebo to the left and right at night for 2 weeks. The daily dose of mometasone furoate is 200 mcg.

DRUG

Mometasone furoate

Four sprays of mometasone furoate 50 mcg are administered to the left and right nostrils in the morning, and four sprays of placebo to the left and right nostrils at night for 2 weeks. The daily dose of mometasone furoate is 400 mcg.

DRUG

Mometasone furoate

One spray of mometasone furoate 50 mcg is administered to the left and right nostrils twice a day (in the morning and at night) for 2 weeks. The daily dose of mometasone furoate is 200 mcg.

DRUG

Mometasone furoate

Two sprays of mometasone furoate 50 mcg are administered to the left and right nostrils twice a day (in the morning and at night) for 2 weeks. The daily dose of mometasone furoate is 400 mcg.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00779545 - A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED) | Biotech Hunter | Biotech Hunter